Suppression of host humoral immunity by Borrelia burgdorferi varies over the course of infectionHost Response and Inflammation Published on 2024-04-222024-09-05 Journal: Infection and Immunity [Category] update2024, [키워드] Adaptive immune response Antibiotic treatment Borrelia burgdorferi immune evasion immunizations Lyme disease SARS-CoV-2 [DOI] 10.1128/iai.00018-24 PMC 바로가기 [Article Type] Host Response and Inflammation
Humoral and cellular immune responses induced by serogroup W135 meningococcal conjugate and polysaccharide vaccinesW135 수막구균 결합 백신 및 다당류 백신에 의해 유도된 체액 및 세포 면역 반응Article Published on 2024-04-192024-08-18 Journal: Vaccine [Category] 파상풍, [키워드] Adaptive immune response Bacterial glycoconjugate vaccine Meningococcal serogroup W135. [DOI] 10.1016/j.vaccine.2024.03.039
Increasing HbA1c is associated with reduced CD8 + T cell functionality in response to influenza virus in a TCR-dependent manner in individuals with diabetes mellitusOriginal Article Published on 2024-01-122024-09-05 Journal: Cellular and Molecular Life Sciences [Category] update2024, [키워드] Adaptive immune response High glucose hyperglycemia T cell receptor complex [DOI] 10.1007/s00018-023-05010-4 PMC 바로가기 [Article Type] Original Article
The Matrix-M™ adjuvant: A critical component of vaccines for the 21 st centuryImmunology Published on 2023-04-272024-09-04 Journal: Human vaccines & immunotherapeutics [Category] 대상포진, [키워드] Adaptive immune response COVID-19 immunogenicity innate immune response Matrix-M™ adjuvant mechanism of action Quillaja saponin Safety SARS-CoV-2 Vaccine [DOI] 10.1080/21645515.2023.2189885 PMC 바로가기 [Article Type] Immunology
Memory B-Cell Development After Asymptomatic or Mild Symptomatic SARS-CoV-2 InfectionArticle Published on 2022-12-282023-07-10 Journal: The Journal of Infectious Diseases [Category] COVID19(2023년), [키워드] Adaptive immune response asymptomatic infection COVID-19 immunity memory B cells mild infection SARS-CoV-2 [DOI] 10.1093/infdis/jiac319 PMC 바로가기
Impaired immune response drives age-dependent severity of COVID-19Article Published on 2022-12-052022-11-15 Journal: The Journal of Experimental Medicine [Category] COVID19(2023년), SARS, 치료제, [키워드] Adaptive immune response Aggravated Antiviral benefit caused characterized combinatorial treatment correlation COVID-19 disease disease severity function IFN IFN-γ IFN-λ immune response Immunity Immunotherapy Impaired increasing age individual interferon mice reversed SARS-COV-2 infection severe COVID-19 severe disease severity of COVID-19 susceptibility Therapeutic treatment type I virus replication [DOI] 10.1084/jem.20220621 PMC 바로가기
The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variantsCoronVac 백신 3차 접종은 SARS-CoV-2 Delta 및 Omicron 변이체를 인식하는 광범위하고 강력한 적응 면역 반응 유도Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adaptive Adaptive immune response B cell B cells boost booster booster dose booster vaccination CD4 CD8 Cell circulating comparable contagious CoronaVac coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine Delta demonstrated detectable domain dose effective elevated elicited fold follicular healthy subject helper T cell Humoral immunity IgA responses immune responses Inactivated vaccine individual induce memory B memory B cell memory B cells neutralization neutralization activities neutralization activity neutralizing activities omicron Omicron variants peaked predominant preserved Protein RBD receiving recognize reduced remained respiratory response SARS-CoV-2 SARS-CoV-2 delta SARS-CoV-2 variant significantly increased spike-specific IgG strain subpopulations sustained T cell T cell responses T cells T cells response vaccination variant variants VOCs [DOI] 10.1080/22221751.2022.2081614 PMC 바로가기 [Article Type] Article
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccinesArticle Published on 2022-11-152023-07-10 Journal: Cell Reports Medicine [Category] COVID19(2023년), [키워드] Adaptive immune response COVID-19 Inactivated vaccine T cell response [DOI] 10.1016/j.xcrm.2022.100793 PMC 바로가기
Exploratory analysis of interleukin-38 in hospitalized COVID-19 patientsArticle Published on 2022-11-012022-11-15 Journal: Immunity, Inflammation and Disease [Category] SARS, 바이오마커, [키워드] Adaptive immune response Admission age Analysis anti-inflammatory effect anti-inflammatory properties binding Biomarker cartilage CD244 CHL1 circulating Clinical data Cohort cohorts Concentration concentrations coronavirus disease correlated correlation COVID-19 COVID-19 patient COVID-19 severity disease dismutase dysregulated enzyme-linked immunosorbent exploratory fatty healthy control healthy controls healthy subjects hospital Hospitalization hospitalized COVID-19 patient hospitalized COVID-19 patients IL-1 Immunoglobulin in viral increase in infections Inflammatory biomarker intensive care interleukin-38 investigated men moderate Mortality no difference outcome plasma positive correlation positively correlated progression Protein proximity extension assay recent receptor reduce retrieved retrospective cohort study SARS-CoV-2 SERPINA12 severity shown subjects thrombocyte TNF TNFRSF9 validation cohort were measured while women [DOI] 10.1002/iid3.712 PMC 바로가기
SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial CellsArticle Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 치료제, [키워드] Activation Adaptive immune response association biochemical Caco2 caused changed chemokine Colon contributed COVID-19 cytokine declining Delta delta variant disease epithelial cell line evade Evolution expected fatality feature highlighting Host Human humans IFN IFN response Infection Innate innate antiviral innate immune response interferon Intervention mechanism multiple mechanism outcome pandemic pathophysiology pathway persistence receptor reduced Replication response resulting RLR pathway robust SARS-CoV-2 SARS-CoV-2 variant severe disease Severe infection severe symptom silent susceptible sustained the disease transcriptomic Treatment vaccination variant variants viral evolution virulence virus with COVID-19 [DOI] 10.1128/spectrum.01604-22 PMC 바로가기